Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
AnMed Health
mi
from
Anderson, SC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
AnMed Health
mi
from
Anderson, SC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Providence Hospital
mi
from
Columbia, SC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Providence Hospital
mi
from
Columbia, SC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Greenville Memorial Hospital
mi
from
Greenville, SC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Greenville Memorial Hospital
mi
from
Greenville, SC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Sanford USD Medical Center
mi
from
Sioux Falls, SD
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Memorial Hospital
mi
from
Chattanooga, TN
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Memorial Hospital
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Wellmont Holston Valley Medical Center
mi
from
Kingsport, TN
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Wellmont Holston Valley Medical Center
mi
from
Kingsport, TN
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Northwest Texas Healthcare System
mi
from
Amarillo, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Northwest Texas Healthcare System
mi
from
Amarillo, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Seton Medical Center Austin
mi
from
Austin, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Seton Medical Center Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Harrison Methodist
mi
from
Fort Worth, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Harrison Methodist
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. Luke's Episcopal Hospital
mi
from
Houston, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. Luke's Episcopal Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Methodist Hospital
mi
from
Houston, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
East Texas Medical Center
mi
from
Tyler, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
East Texas Medical Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Carilion Roanoke Memorial Hospital
mi
from
Roanoke, VA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Carilion Roanoke Memorial Hospital
mi
from
Roanoke, VA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Winchester Medical Center
mi
from
Winchester, VA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Winchester Medical Center
mi
from
Winchester, VA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Providence Everett Medical Center
mi
from
Everett, WA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Providence Everett Medical Center
mi
from
Everett, WA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Liverpool Hospital
mi
from
Liverpool,
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Liverpool Hospital
mi
from
Liverpool,
Click here to add this to my saved trials
Interleukin-1 Blockade in HF With Preserved EF
Interleukin-1 Blockade in Heart Failure With Preserved Ejection Fraction (HFpEF): a Randomized Placebo-controlled Double Blinded Study (D-HART2)
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Interleukin-1 Blockade in HF With Preserved EF
Interleukin-1 Blockade in Heart Failure With Preserved Ejection Fraction (HFpEF): a Randomized Placebo-controlled Double Blinded Study (D-HART2)
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Interleukin-1 Blockade in HF With Preserved EF
Interleukin-1 Blockade in Heart Failure With Preserved Ejection Fraction (HFpEF): a Randomized Placebo-controlled Double Blinded Study (D-HART2)
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Interleukin-1 Blockade in HF With Preserved EF
Interleukin-1 Blockade in Heart Failure With Preserved Ejection Fraction (HFpEF): a Randomized Placebo-controlled Double Blinded Study (D-HART2)
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Prospective Observation of Cardiac Safety With Proteasome Inhibition
Prospective Observation of Cardiac Safety With Proteasome Inhibition
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Prospective Observation of Cardiac Safety With Proteasome Inhibition
Prospective Observation of Cardiac Safety With Proteasome Inhibition
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Prospective Observation of Cardiac Safety With Proteasome Inhibition
Prospective Observation of Cardiac Safety With Proteasome Inhibition
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvania/Smilow Center for Translational Research
mi
from
Philadelphia, PA
Prospective Observation of Cardiac Safety With Proteasome Inhibition
Prospective Observation of Cardiac Safety With Proteasome Inhibition
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania/Smilow Center for Translational Research
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated:  12/31/1969
Lucile Packard Children's Hospital at Stanford
mi
from
Stanford, CA
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated: 12/31/1969
Lucile Packard Children's Hospital at Stanford
mi
from
Stanford, CA
Click here to add this to my saved trials
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated:  12/31/1969
MedStar Georgetown Transplant Institute
mi
from
Washington,
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated: 12/31/1969
MedStar Georgetown Transplant Institute
mi
from
Washington,
Click here to add this to my saved trials
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated:  12/31/1969
University of Miami Health System
mi
from
Miami, FL
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated: 12/31/1969
University of Miami Health System
mi
from
Miami, FL
Click here to add this to my saved trials
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern
mi
from
Dallas, TX
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
Status: Enrolling
Updated:  12/31/1969
Keck Medical Center of USC
mi
from
Los Angeles, CA
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
Status: Enrolling
Updated: 12/31/1969
Keck Medical Center of USC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
Status: Enrolling
Updated:  12/31/1969
Lac & Usc Medical Center
mi
from
Los Angeles, CA
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
Status: Enrolling
Updated: 12/31/1969
Lac & Usc Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oxygen Consumption-based Assessments of Hemodynamics in Neonates Following Congenital Heart Surgery (Oxy-CAHN Study)
Oxygen Consumption-based Assessments of Hemodynamics in Neonates Following Congenital Heart Surgery (Oxy-CAHN Study)
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Oxygen Consumption-based Assessments of Hemodynamics in Neonates Following Congenital Heart Surgery (Oxy-CAHN Study)
Oxygen Consumption-based Assessments of Hemodynamics in Neonates Following Congenital Heart Surgery (Oxy-CAHN Study)
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Baptist Medical Center Jacksonville
mi
from
Jacksonville, FL
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Baptist Medical Center Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Radiology Imaging Associates
mi
from
Englewood, CO
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Radiology Imaging Associates
mi
from
Englewood, CO
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
The Emory Clinic
mi
from
Atlanta, GA
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Baptist Physician's Lexington
mi
from
Lexington, KY
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Baptist Physician's Lexington
mi
from
Lexington, KY
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
mi
from
Lexington, KY
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Tufts University Medical Center
mi
from
Boston, MA
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Tufts University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Kaleida Health/University of Buffalo
mi
from
Buffalo, NY
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Kaleida Health/University of Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Stony Brook University
mi
from
Stony Brook, NY
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Stony Brook University
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials